Detalles de la búsqueda
1.
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study.
Haematologica
; 108(8): 2091-2100, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36632738
2.
Predictors of ibrutinib-associated atrial fibrillation: 5-year follow-up of a prospective study.
Hematol Oncol
; 41(3): 363-370, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36762406
3.
Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study.
Hematol Oncol
; 41(5): 877-883, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37392141
4.
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia.
Hematol Oncol
; 41(3): 567-570, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36190298
5.
Decitabine treatment for an unusual case of atypical chronic myeloid leukemia (aCML) with a concomitant chronic lymphocytic leukemia (CLL).
Hematol Oncol
; 37(4): 505-507, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31102420
6.
Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?
Front Immunol
; 14: 1062376, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37122737
7.
Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study.
Cancers (Basel)
; 15(11)2023 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37296954
8.
Chronic lymphocytic leukemia and prognostic models: A bridge between clinical and biological markers.
Am J Hematol
; 92(7): E135-E137, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28383110
9.
Early detection of pulmonary hypertension in primary myelofibrosis: The role of echocardiography, cardiopulmonary exercise testing, and biomarkers.
Am J Hematol
; 92(4): E47-E48, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28109034
10.
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study.
Front Oncol
; 12: 1033413, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36479077
11.
The Role of Novel Agents in Treating CLL-Associated Autoimmune Hemolytic Anemia.
J Clin Med
; 10(10)2021 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34065833
12.
Epidemiology and treatment approaches in management of invasive fungal infections in hematological malignancies: Results from a single-centre study.
PLoS One
; 14(5): e0216715, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31071175
13.
Predictors of atrial fibrillation in ibrutinib-treated CLL patients: a prospective study.
J Hematol Oncol
; 11(1): 79, 2018 06 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29891001
14.
Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort.
Blood Adv
; 7(4): 525-528, 2023 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35930765
15.
Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients With Lymphoproliferative Disorders on BTKi.
Hemasphere
; 7(5): e880, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37153871
16.
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy).
Blood Adv
; 4(13): 2996-2999, 2020 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32609844
17.
Lymphocytic variant hypereosinophilia: a challenging diagnosis of a rare disease with pleomorphic clinical picture.
Eur J Intern Med
; 57: e22-e24, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30100216
Resultados
1 -
17
de 17
1
Próxima >
>>